IJGC conversations

ijgcgroup

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

  1. MAR 2

    De-escalation in Gynecologic Oncology

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Alex Melamed and René Pareja to discuss De-escalation in Gynecologic Oncology.   Alex Melamed, MD, MPH, is a gynecologic oncologist and clinical outcomes researcher in the Department of Obstetrics and Gynecology at Mass General Hospital and an Associate Professor at Harvard Medical School. He co-directs the Inference Lab in MGH's Vincent Department of Obstetrics and Gynecology. Dr. Melamed's research focuses on applying methods that provide meaningful insights from observational data. In particular, his work explores how focusing on temporal and spatial variation in clinical practice can help to uncover how health care affects patient outcomes. Some of his research focuses on increasing understanding of how surgical care affects the lives of cancer patients. Dr. Melamed is an associate editor of the International Journal of Gynecologic Cancer.    Dr. René Pareja is a Gynecologist and Obstetrician, graduated from Universidad Pontificia Bolivariana in Medellín, Colombia in 2000; he finished his training in Gynecologic Oncology in 2003, from Pontificia Universidad Javeriana and Instituto Nacional de Cancerología in Bogotá, Colombia. He is a minimally invasive surgeon, graduated from Corporación de Estudios de la Salud (CES) in 2013. He currently works at Astorga Oncology Clinic in Medellín and at National Cancer Institute in Bogotá, Colombia. Dr. Pareja serves as a reviewer for more than 20 journals. He has authored or co-authored nine book chapters and more than fifty publications in peer-reviewed journals. Currently he is an Associate Editor of the International Journal of Gynaecological Cancer and is a Council member of the International Gynecological Cancer Society Council. He also serves as an international mentor for the Hospital General San Juan de Dios in Guatemala through the IGCS Global Curriculum & Mentorship Program.Some of his research has influenced how gynecologic oncologists treat cancer and has been published in important medical journals, like the New England Journal of Medicine, JAMA, and Journal of Clinical Oncology.

    40 min
  2. FEB 2

    Mirvetuximab in Low-Grade Ovarian Cancer with Alessandro D. Santin

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alessandro D. Santin to discuss Mirvetuximab in Low-Grade Ovarian Cancer.   Dr. Alessandro D. Santin, a native of Italy, graduated with honors from the University of Brescia, Italy and received his postgraduate training in Obstetrics & Gynecology at the same University. He served a fellowship in Gynecologic Oncology at the University of California, Irvine and an International Fellowship in the Division of Gynecologic Oncology at the University of Arkansas for Medical Sciences, Little Rock, Arkansas. Dr. Santin joined the faculty in the Section of Gynecologic Oncology in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale University as Professor as of July 2008. Dr. Santin has more than 400 original research and peer-reviewed publications including multiple review articles and book chapters and he has written extensively on various topics, including cancer of the ovary, endometrium and cervix as well as on tumor immunology and immunotherapy. Dr. Santin's clinical interests include the use of immunotherapy in ovarian, cervical and endometrial carcinoma patients with disease resistant/refractory to standard treatment, therapeutic vaccines against Human Papillomavirus (HPV) infected genital tumors, and the development of personalized treatment modalities including monoclonal antibodies and antibody-drug-conjugates (ADC) against chemotherapy resistant gynecologic tumors.

    39 min

Ratings & Reviews

5
out of 5
3 Ratings

About

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

You Might Also Like